Watch for This Small-Cap Scenario<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />4/20/2007 8:36 AM EDT<br />Click here for more stories by Rev Shark <br /><br />"Beauty, like ice, our footing does betray; Who can tread sure on the smooth, slippery way: Pleased with the surface, we glide swiftly on, And see the dangers that we cannot shun." <br /><br />-- John Dryden <br /><br />Although the major indices have acted quite well the last couple days and blithely shrug off the negatives, there has been some troubling action under the surface. The 5% swoon in China barely made a ripple in the US markets yesterday, and European stocks are bouncing back very strongly this morning. <br /><br />There clearly is strong underlying buying interest, at least in big-caps, but the poor breadth and relative weakness in smaller stocks is a bit troubling. We had similar action last fall with the big stocks like MSFT and WMT driving the indices. The small-caps eventually played catch-up but for quite a while many market players were complaining about the less-than-stellar action in the little guys as well as in momentum stocks. <br /><br />The question we have now is whether we are seeing a replay of last fall's action. We have strength in a few names like INTC and KO, which are making the DJIA and SP500 look good, while the overall market has nearly 2 stocks declining for each 1 that advanced. Are the small-caps going to play catch-up again or does their weakness signify something different this time? <br /><br />The conventional wisdom is that a narrow market is not a healthy market. As concentrated buying drives up a small group of names, they eventually become expensive relative to the rest of the market so logically the buying should spread to other areas. If that doesn't occur, then arguably the narrow buying was just some focused speculative excess that usually has a limited life span. <br /><br />Jim Cramer has recently made the argument that the market is undergoing a transition in which multiples will expand, which is what is driving big-caps. If that is really happening, then the increase in PE ratios should be across the board as the relative value of stocks to each other really isn't changing. Perhaps market players have so much liquidity that they are willing to pay higher prices for the slower moving but more reliable big-caps, but shouldn't some of that liquidity also lift good small-caps and momentum names? <br /><br />We will have to watch breadth and the relative strength in small-caps. If that divergence continues it will create some good trading as either the small-caps play catch up or the big caps correct. <br /><br />We have a strong start shaping up this morning following a good report from Google and a sharp rebound overseas. The news flow is quite positive and keeping the mood upbeat. Gold has bounced back from a hard hit yesterday and oil is holding steady. <br />--------------------------<br />Ülespoole avanevad:<br /><br />Gapping up on strong earnings/guidance: SYNL +11.6%, INFA +5.0%, CAT +4.9%, ISRG +3.9%, PKTR +2.5%... M&A: GCO +12.2% (Foot Locker proposes acquisition of GCO for $46/share in cash)... Rebound in Asian stock markets lift China stocks, particularly solar: JADE +6.6%, TSL +5.5%, SOLF +4.0%, JASO +3.6%... Small-cap cancer/biotech stocks continue their news-driven rally: EPCT +81.6% (announces Myriad Genetics presented studies characterizing vascular disruption capabilities of Azixa), AVNR +9.7% (momentum), MGRM +7.7% (tgt raised to $3 at ThinkEquity), AMRN +6.4% (momentum), CBLI +6.2% (Protectan CBLB612 demonstrates efficacy in stimulating proliferation and mobilization of bone marrow stem cells in primate model), POZN +5.9% (initiated with a Buy and $28 tgt at Citi), NSTK +5.5% (Cramer positive on stock), ENZN +5.1% & SKYE +3.5% (ENZN granted full approval for DepoCyt for treatment of Lymphomatous Meningitis; ENZN licensed North American rights from SKYE)... Other news: HRB +8.8% (announces agreement to sell Option One Mortgage), RMKR +5.1% (prices 4.16 mln share offering at $8.50/share), HSOA +4.7% (profiled in BusinessWeek), NAPS +4.6% (Circuit City teams with NAPS to launch new digital music service).<br /><br />Allapoole avanevad:<br /><br />Gapping down on weak earnings/guidance: MNT -18.3% (also downgraded to Underperform at Piper), RNOW -16.9% (also multiple downgrades), RHI -10.0% (also downgraded to Sell at Stifel), STMP -9.5% (also downgraded to Neutral at First Albany), ENER -8.2% (guides Q3 revs below consensus, announces organizational restructuring plan), SIRF -6.7%, COF -5.5% (also multiple downgrades), CREE -1.6%... Other news: EVVV -5.5% (prices 8.75 mln share offering at $19/share), HDNG -3.4% (prices 2.2 mln share secondary at $23.50), AVCI -2.1% (continuing weakness after Wednesday's report & restructuring announcement), HTLD -2.1% (downgraded to Hold at Stifel), DPTR -1.9% (prices 6.2 mln share offering at $20.50/share), TZOO -1.8% (downgraded to Buy at First Albany).